The management of the obese diabetic patient

Keyphrases

• Glycemic Control 100%
• Weight Gain 75%
• Insulin 50%
• Insulin Resistance 50%
• Oral Agents 50%
• Weight Reduction 25%
• Obesity Prevalence 25%
• United States 25%
• High Dose 25%
• Diabetic Patients 25%
• Monotherapy 25%
• Effective Treatment 25%
• Diabetes 25%
• Insulin Therapy 25%
• Type 2 Diabetes Mellitus (T2DM) 25%
• Weight Control 25%
• Explode 25%
• Pharmacologic Agents 25%
• Avail 25%
• NHANES III 25%
• Morbid Obesity 25%
• Diabetic 25%
• Pharmacological Therapy 25%
• Obese Patients 25%
• Termbase 25%
• Gastric Bypass 25%
• Sibutramine 25%
• Lifestyle Modification 25%
• Reducing Agent 25%
• Exogenous Insulin 25%
• Diabetes Prevalence 25%
• Bariatric Surgery 25%
• Massive Weight Loss 25%
• Glycemia 25%
• Oral Hypoglycemic Agents 25%
• Vicious Cycle 25%
• Cell Dysfunction 25%
• Vascular Complications 25%

Nursing and Health Professions

• Diabetes Mellitus 50%
• Insulin Resistance 50%
• Prevalence 25%
• Non Insulin Dependent Diabetes Mellitus 25%
• Antidiabetic Agent 25%
• Insulin Treatment 25%
• Sibutramine 25%
• Monotherapy 25%
• National Health and Nutrition Examination Survey 25%
• Glucose Blood Level 25%
• Bariatric Surgery 25%
• Drug Megadose 25%
• Body Weight Loss 25%
• Lifestyle Modification 25%
• Gastric Bypass Surgery 25%
• Weight Control 25%
• Diseases 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Diabetes Mellitus 50%
• Insulin Resistance 50%
• Prevalence 25%
• Monotherapy 25%
• Antidiabetic Agent 25%
• Sibutramine 25%
• Reducing Agent 25%
• Non Insulin Dependent Diabetes Mellitus 25%
• Diseases 25%